Kobayashi Pharmaceutical Co., Ltd. - significant increase, upgrading to buy recommendation by domestic securities firms based on the assessment of resolving the red koji issue.

Fisco Japan · Nov 25 12:08

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

小林製薬---大幅続伸、紅こうじ問題収束と判断し国内証券では買い推奨に格上げ

Kobayashi Pharmaceutical Co., Ltd. - significant increase, upgrading to buy recommendation by domestic securities firms based on the assessment of resolving the red koji issue.

Risk Disclaimer

Statement